# FDA Inspection 1248367 - LifeShare Blood Center - July 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/lifeshare-blood-center/7a042799-20c7-4906-b0ae-992b72de63ad
Source feed: FDA_Inspections

> FDA Inspection 1248367 for LifeShare Blood Center on July 12, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1248367
- Company Name: LifeShare Blood Center
- Inspection Date: 2024-07-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1178705 - 2022-09-01](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-center/d89ee1ee-4836-47b8-99d9-bc306a72b0c7)
- [FDA Inspection 1178705 - 2022-09-01](https://www.keypedia.com/records/fda_inspections/lifeshare-blood-center/23ef2bb2-0e5c-4de4-ab22-811cc4f1e1c7)

Company: https://www.keypedia.com/companies/lifeshare-blood-center/fffcc179-daf3-48cf-8a9e-0423632a6827

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d